Zestril (generic)
Generic name: lisinopril
Manufactured by: Various
Therapeutic category: Cardiology
Tariff Status Explanation
This drug is a generic or biosimilar and is fully exempt from all Section 232 pharmaceutical tariffs. No price impact from tariffs is expected.
Key Dates
Sept 29, 2026
Section 232 tariff effective for all other companies
April 2, 2030
Onshoring plan exemptions expire (revert to 100%)
What Can You Do?
- →Check if your manufacturer has signed an MFN deal. View all MFN deals →
- →Use our Savings Guide to find discount programs, patient assistance, and alternatives before tariffs take effect.
Will Zestril (generic) Cost More Due to Tariffs?
Zestril (generic) (lisinopril) is manufactured by Various and is classified as a cardiology medication. As a generic drug, lisinopril is fully exempt from all Section 232 pharmaceutical tariffs. The tariffs apply only to patented brand-name drugs, not generic equivalents.
Remember that the tariff applies to the drug's acquisition cost — the price pharmacies pay to purchase the drug — not necessarily your final copay. Patients with insurance may see the tariff impact appear gradually through formulary changes or premium increases. Uninsured patients and those paying cash prices may see more direct impacts.